切换至 "中华医学电子期刊资源库"
高级检索
中华肝脏外科手术学电子杂志

中华肝脏外科手术学电子杂志 ›› 2014, Vol. 03 ›› Issue (06) : 345 -349. doi: 10.3877/cma.j.issn.2095-3232.2014.06.004

所属专题： 机器人手术； 文献；

临床研究

机器人辅助胰头十二指肠切除术治疗胰头部恶性肿瘤
施昱晟1, 詹茜1, 邓侠兴1, 金佳斌1, 吴志翀1, 陈皓1, 沈柏用1, 彭承宏1,†(), 李宏为1   
  1. 1. 200025　上海交通大学医学院附属瑞金医院普外科　上海交通大学医学院胰腺疾病研究所
  • 收稿日期:2014-08-15 出版日期:2014-12-10
  • 通信作者: 彭承宏
  • 基金资助:
    卫生部卫生行业科研专项(201002020); 上海市科委科研计划项目(11JC1407800)

Pancreaticoduodenectomy with assistance of robotic operation system for pancreatic head cancer

Yusheng Shi1, Qian Zhan1, Xiaxing Deng1, Jiabin Jin1, Zhichong Wu1, Hao Chen1, Baiyong Shen1, Chenghong Peng1,†(), Hongwei Li1   

  1. 1. Department of General Surgery, Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Research Institute of Pancreatic Diseases Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200025, China
  • Received:2014-08-15 Published:2014-12-10
  • Corresponding author: Chenghong Peng
  • About author:
    Corresponding author: Peng Chenghong, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

施昱晟, 詹茜, 邓侠兴, 金佳斌, 吴志翀, 陈皓, 沈柏用, 彭承宏, 李宏为. 机器人辅助胰头十二指肠切除术治疗胰头部恶性肿瘤[J]. 中华肝脏外科手术学电子杂志, 2014, 03(06): 345-349.

Yusheng Shi, Qian Zhan, Xiaxing Deng, Jiabin Jin, Zhichong Wu, Hao Chen, Baiyong Shen, Chenghong Peng, Hongwei Li. Pancreaticoduodenectomy with assistance of robotic operation system for pancreatic head cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2014, 03(06): 345-349.

目的

探讨机器人辅助胰头十二指肠切除术治疗胰头部恶性肿瘤的临床应用价值。

方法

回顾性分析2010年5月至2014年4月上海瑞金医院应用达芬奇机器人辅助胰头十二指肠切除术治疗的38例胰头部恶性肿瘤患者临床资料。其中男25例，女13例；平均年龄（59±10）岁。所有患者均签署知情同意书，符合医学伦理学规定。采用"五孔法"置入3枚机器人专用套管（Trocar）及1枚镜头Trocar和1枚辅助Trocar，放入机器人臂，机器人辅助下行胰头十二指肠切除术。观察患者围手术期情况，包括手术时间、术中出血量、手术情况、术后并发症和生存情况等。

结果

38例均顺利完成，完全切除（R0）切除率97%（37/38），R1切除率3%（1/38），中位手术时间413（210～520）min，术中出血量320（50～1 100）ml，淋巴结清扫数15 (2～24)个。术后住院时间20 (7～36) d，术后并发症发生率42%（16/38），其中胰瘘8例、胆瘘2例、术后感染6例。术后生存时间25（3～42）个月，无瘤生存时间14（5～28）个月。

结论

采取机器人辅助胰头十二指肠切除术切除胰头部恶性肿瘤安全、可行。

关键词: 胰腺肿瘤, 胰十二指肠切除术, 达芬奇机器人手术系统, 治疗结果, 手术后并发症, 淋巴结切除术
Objective

To investigate the clinical application value of pancreaticoduodenectomy with the assistance of robotic operation system for pancreatic head cancer.

Methods

Clinical data of 38 patients with pancreatic head cancer undergoing pancreaticoduodenectomy using Da Vinci Si robotic system in Shanghai Ruijin Hospital from May 2010 to April 2014 were analyzed retrospectively. There were 25 males and 13 females with the mean age of (59±10) years old. The informed consents of all patients were obtained and the ethical committee approval was received. Three robotic exclusive Trocars, 1 camera Trocar and 1 assistant Trocar were inserted using 5-port approach and the robotic arms were inserted. Pancreaticoduodenectomy was performed under the assistance of robotic system. The perioperative situation including operation time, intraoperative blood loss, operation, postoperative complication and survive were observed.

Results

All the operations of 38 cases were finished successfully with radical (R0) resection rate 97% (37/38), R1 resection rate 3% (1/38) and the median operation time 413(210-520)min, intraoperative blood loss 320(50-1 100)ml, lymphnode clearance number 15(2-24), postoperative hospital stay 20(7-36)d. The incidence of postoperative complication was 42% (16/38) including pancreatic fistula (n=8), biliary fistula (n=2), postoperative infection (n=6). The postoperative survival time was 25(3-42) months and disease-free survival time was 14(5-28) months.

Conclusion

Pancreaticoduodenectomy with the assistance of robotic operation system is safe and feasible for resecting pancreatic head cancer.

Key words: Pancreatic neoplasms, Pancreaticoduodenectomy, Da Vinci Si robotic system, Treatment outcome, Postoperative complications, Lymph node excision
图1 机器人辅助胰头十二指肠切除手术过程
[1]
Brennan DD, Zamboni GA, Raptopoulos VD, et al. Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT[J]. Radiographics, 2007, 27(6):1653-1666.
[2]
Vollmer CJ, Sanchez N, Gondek S, et al. A root-cause analysis of mortality following major pancreatectomy[J]. J Gastrointest Surg, 2012, 16(1):89-103.
[3]
Pessaux P, Sauvanet A, Mariette C, et al. External pancreatic duct stent decreases pancreatic fistula rate after pancreaticoduodenectomy: prospective multicenter randomized trial[J]. Ann Surg, 2011, 253(5):879-885.
[4]
Corcione F, Pirozzi F, Cuccurullo D, et al. Laparoscopic pancreaticoduodenectomy: experience of 22 cases[J]. Surg Endosc, 2013, 27(6):2131-2136.
[5]
卢榜裕，李建军．腹腔镜胰十二指肠切除术的发展现状与前景[J]． 微创医学，2010, 5(2):91-94.
[6]
沈柏用，刘钦，邓侠兴，等．达芬奇机器人手术系统行胰十二指肠切除术的临床疗效[J]．中华消化外科杂志，2012, 11(1):79-81.
[7]
Giulianotti PC, Coratti A, Angelini M, et al. Robotics in general surgery: personal experience in a large community hospital[J]. Arch Surg, 2003, 138(7):777-784.
[8]
Buchs NC, Addeo P, Bianco FM, et al. Robotic versus open pancreaticoduodenectomy: a comparative study at a single institution[J]. World J Surg, 2011, 35(12):2739-2746.
[9]
周宁新，陈军周，刘全达，等．达芬奇机器人手术系统和开腹胰十二指肠切除术的比较[J]．中华消化外科杂志，2010, 9(2):101-104.
[10]
Lai EC, Yang GP, Tang CN. Robot-assisted laparoscopic pancreaticoduodenectomy versus open pancreaticoduodenectomy: a comparative study[J]. Int J Surg, 2012, 10(9):475-479.
[11]
Chalikonda S, Aguilar-Saavedra JR, Walsh RM. Laparoscopic robotic-assisted pancreaticoduodenectomy: a case-matched comparison with open resection[J]. Surg Endosc, 2012, 26(9):2397-2402.
[12]
Lewis R, Drebin JA, Callery MP, et al. A contemporary analysis of survival for resected pancreatic ductal adenocarcinoma[J]. HPB, 2013, 15(1):49-60.
[13]
Konstantinidis IT, Deshpande V, Zheng H, et al. Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma?[J]. J Gastrointest Surg, 2010, 14(2):261-267.
[14]
Fatima J, Schnelldorfer T, Barton J, et al. Pancreatoduodenectomy for ductal adenocarcinoma: implications of positive margin on survival[J]. Arch Surg, 2010, 145(2):167-172.
[15]
Jamieson NB, Chan NI, Foulis AK, et al. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma[J]. J Gastrointest Surg, 2013, 17(3):511-521.
[16]
Konstantinidis IT, Warshaw AL, Allen JN, et al. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? what is a "true" R0 resection?[J]. Ann Surg, 2013, 257(4):731-736.
[17]
Jamieson NB, Foulis AK, Oien KA, et al. Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinoma[J]. Ann Surg, 2010, 251(6):1003-1010.
[1] 王宏宇. 固定与活动平台假体在全膝关节置换术中的应用价值[J]. 中华关节外科杂志(电子版), 2023, 17(06): 871-876.
[2] 许正文, 李振, 侯振扬, 苏长征, 朱彪. 富血小板血浆联合植骨治疗早期非创伤性股骨头坏死[J]. 中华关节外科杂志(电子版), 2023, 17(06): 773-779.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 逄世江, 黄艳艳, 朱冠烈. 改良π形吻合在腹腔镜全胃切除消化道重建中的安全性和有效性研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 66-69.
[5] 杨体飞, 杨传虎, 陆振如. 改良无充气经腋窝入路全腔镜下甲状腺手术对喉返神经功能的影响研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 74-77.
[6] 陈垚, 徐伯群, 高志慧. 改良式中间上入路根治术治疗甲状腺癌的有效性安全性研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 619-622.
[7] 陈大敏, 曹晓刚, 曹能琦. 肥胖对胃癌患者手术治疗效果的影响研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 651-653.
[8] 张海涛, 康婵娟, 翟静洁. 胰管支架置入治疗急性胆源性胰腺炎效果观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 654-657.
[9] 宋钰, 赵阳, 王惠君, 廖新华. 术前BMI与可切除胃癌患者术后远期生存的关系[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 530-533.
[10] 汪毅, 许思哲, 任章霞. 胸乳入路腔镜单侧甲状腺叶切除术与开放手术对分化型甲状腺癌患者术后恢复的影响[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 542-545.
[11] 陈俊宇, 崔宇. TAPP治疗腹股沟嵌顿疝的临床分析[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 546-549.
[12] 赵新亮, 荆克杰, 樊红艳, 王妮, 葸根. 腹腔镜完全腹膜外补片与腹腔内补片治疗两侧下腹壁切口疝的临床对比观察[J]. 中华普外科手术学杂志(电子版), 2023, 17(05): 554-557.
[13] 潘冰, 吕少诚, 赵昕, 李立新, 郎韧, 贺强. 淋巴结清扫数目对远端胆管癌胰十二指肠切除手术疗效的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 608-612.
[14] 崔佳琪, 吴迪, 陈海艳, 周惠敏, 顾元龙, 周光文, 杨军. TACE术后并发肝脓肿的临床诊治分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 688-693.
[15] 王峰杰, 王礼光, 廖珊, 刘颖, 符荣党, 陈焕伟. 腹腔镜右半肝切除术治疗肝癌的安全性与疗效[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 517-522.
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号